Ovarian cancer stage III
Clinical trials for Ovarian cancer stage III explained in plain language.
Never miss a new study
Get alerted when new Ovarian cancer stage III trials appear
Sign up with your email to follow new studies for Ovarian cancer stage III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine combo aims to outsmart ovarian cancer resistance
Disease control Not yet recruitingThis phase 2 trial tests whether a peptide vaccine (NY-ESO-1) combined with an immunotherapy drug (toripalimab-tpzi) can prevent resistance to treatment in 24 women with stage III/IV ovarian cancer that no longer responds to platinum chemotherapy. The vaccine primes the immune sy…
Matched conditions: OVARIAN CANCER STAGE III
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can tumor markers guide future ovarian cancer treatments?
Knowledge-focused Not yet recruitingThis study examines tumor samples from 320 Latin American women with advanced ovarian, fallopian tube, or peritoneal cancer to describe the presence of certain markers (FRα, HER2, PD-L1, HRD, and BRCA). Researchers will collect medical history and test archived tumor tissue to se…
Matched conditions: OVARIAN CANCER STAGE III
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC